Abstract
Cannabis has been used as a drug for centuries, possibly much longer before
it was recognised as an illegal substance. The prime psychoactive property is marked
on the 9-THC compound. The cannabinoids replicate the action of endocannabinoids
by stimulating receptors in the central nervous system and lymphatic system via
diligent CB1 and CB2, respectively. Cannabinoids, on the other hand, are well known
for their dependency, which is less severe than that of other drugs that can be abused.
Cannabis' anti-tumor and anti-cancer potential was only discovered at the turn of the
twentieth century. Cannabis consumption has been reported to benefit patients with
cancer by suppressing nausea, curbing vomiting, elevating appetite, alleviating pain,
and pacifying anxiety. Studies envisage that the up-regulation of CB receptors and their
associated endogenous ligands correlates with the suppression of tumours. Patients
have found cannabis to be effective in reducing side effects and relieving pain when
used in conjunction with chemotherapy. Though cannabis prescription is restricted
under federal laws in many countries, its lucrative efficacy profile has pushed
regulators to reconsider its use in medical causes such as cancer. This chapter is an
attempt to emphasise the biological role of cannabis in cancer pathophysiology